Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosis. 2005

Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
Department of Biochemistry, National University of Singapore, 8 Medical Drive, 117597, Singapore. bchpcr@nus.edu.sg

OBJECTIVE Hydrogen sulfide (H(2)S) is a prominent gaseous constituent of the gastrointestinal (GI) tract with known cytotoxic properties. Endogenous concentrations of H(2)S are reported to range between 0.2-3.4 mmol/L in the GI tract of mice and humans. Considering such high levels we speculate that, at non-toxic concentrations, H(2)S may interact with chemical agents and alter the response of colonic epithelium cells to such compounds. The GI tract is a major site for the absorption of phytochemical constituents such as isothiocyanates, flavonoids, and carotenoids, with each group having a role in the prevention of human diseases such as colon cancer. The chemopreventative properties of the phytochemical agent beta-phenyethyl isothiocyanate (PEITC) are well recognized. However, little is currently known about the physiological or biochemical factors present in the GI tract that may influence the biological properties of ITCs. The current study was undertaken to determine the effects of H(2)S on PEITC mediated apoptosis in colon cancer cells. METHODS Induction of apoptosis by PEITC in human colon cancer HCT116 cells was assessed using classic apoptotic markers namely SubG1 population analysis, caspase-3 like activity and nuclear fragmentation and condensation coupled with the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide) viability assay and LDH leakage. RESULTS PEITC significantly induced apoptosis in HCT116 cells as assessed by SubG1 population formation, nuclear condensation, LDH leakage and caspase-3 activity after 24 h, these data being significant from control groups (P<0.01). In contrast, co-treatment of cells with physiological concentrations of H2S (0.1-1 mmol/L) prevented PEITC mediated apoptosis as assessed using the parameters described. CONCLUSIONS PEITC effectively induced cell death in the human adenocarcinoma cell line HCT116 in vitro through classic apoptotic mechanisms. However, in the presence of H(2)S, apoptosis was abolished. These data suggest that H(2)S may play a significant role in the response of colonic epithelial cells to beneficial as well as toxic agents present within the GI tract.

UI MeSH Term Description Entries
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006862 Hydrogen Sulfide A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed) Hydrogen Sulfide (H2(Sx)),Hydrogen Sulfide (H2S2),Hydrogen Sulfide (H2S3),Sulfide, Hydrogen
D016588 Anticarcinogenic Agents Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. Anti-Carcinogenic Agents,Anti-Carcinogenic Drugs,Anti-Carcinogenic Effect,Anti-Carcinogenic Effects,Anticarcinogenic Drugs,Anticarcinogenic Effect,Anticarcinogenic Effects,Anticarcinogens,Agents, Anti-Carcinogenic,Agents, Anticarcinogenic,Anti Carcinogenic Agents,Anti Carcinogenic Drugs,Anti Carcinogenic Effect,Anti Carcinogenic Effects,Drugs, Anti-Carcinogenic,Drugs, Anticarcinogenic,Effect, Anti-Carcinogenic,Effect, Anticarcinogenic,Effects, Anti-Carcinogenic,Effects, Anticarcinogenic
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D017953 Isocyanates Organic compounds that contain the -NCO radical. Isocyanate
D019328 Buthionine Sulfoximine A synthetic amino acid that depletes glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition of this enzyme is a critical step in glutathione biosynthesis. It has been shown to inhibit the proliferative response in human T-lymphocytes and inhibit macrophage activation. (J Biol Chem 1995;270(33):1945-7) Sulfoximine, Buthionine

Related Publications

Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
July 2003, Cellular and molecular life sciences : CMLS,
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
February 2012, Journal of cardiovascular pharmacology,
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
January 2019, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
January 2020, Oxidative medicine and cellular longevity,
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
June 2012, Oncology reports,
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
January 2022, Molecules (Basel, Switzerland),
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
September 2017, International journal of molecular sciences,
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
March 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
October 2009, Diabetes,
Peter Rose, and Philip-K Moore, and Shen-Han Ming, and Ong-Choon Nam, and Jeffrey-S Armstrong, and Matt Whiteman
January 2005, The international journal of biochemistry & cell biology,
Copied contents to your clipboard!